Tricyclic

Tricyclic Antidepressants

Tricyclic antidepressants (TCAs) are a class of medications used primarily as antidepressants. They were discovered in the early 1950s and were among the first antidepressants to be developed. TCAs are named after their chemical structure, which contains three rings of atoms.

History

The first TCA, imipramine, was discovered in the 1950s and was initially used to treat schizophrenia. However, it was soon found to be more effective as an antidepressant. This discovery led to the development of other TCAs, such as amitriptyline and doxepin.

Mechanism of Action

TCAs work by inhibiting the reuptake of neurotransmitters such as serotonin and norepinephrine, increasing their levels in the brain. This action helps alleviate symptoms of depression. However, TCAs also affect other neurotransmitter systems, which can lead to a range of side effects.

Uses

While primarily used to treat major depressive disorder, TCAs are also prescribed for other conditions such as anxiety disorders, chronic pain, and insomnia. Some TCAs, like clomipramine, are used to treat obsessive-compulsive disorder.

Side Effects

Common side effects of TCAs include dry mouth, constipation, urinary retention, blurred vision, and sedation. Due to their potential to cause cardiac arrhythmias, they are considered more dangerous in overdose compared to other antidepressants.

Examples

Some well-known TCAs include:

• Imipramine
• Amitriptyline
• Doxepin
• Nortriptyline
• Desipramine

Related Pages

• Selective serotonin reuptake inhibitor
• Monoamine oxidase inhibitor
• Antidepressant

Gallery

• 
  Dibenzazepine
• 
  Phenothiazine
• 
  Imipramine
• 
  Amitriptyline
• 
  Iprindole
• 
  Tianeptine
• 
  Doxepin
• 
  Chlorpromazine
• 
  Thioridazine
• 
  Chlorprothixene
• 
  Loxapine
• 
  Clozapine
• 
  Promethazine
• 
  Cyproheptadine
• 
  Dimebolin
• 
  Loratadine
• 
  Rupatadine
• 
  Carbamazepine
• 
  Carvedilol
• 
  Cyclobenzaprine
• 
  Pizotifen